Introduktion

2007 - 2019 KAS Herlev, Radiologisk afd X, overlæge

2007 - 2007 KAS Herlev, Radiologisk afd X, (konst. overlæge)

2006 - 2006 KAS Herlev, Radiologisk afd X, (afdelingslæge)

2005 - 2006 Hvidovre Hospital (afdelingslæge)

2004 - 2005 Roskilde Sygehus

2003 - 2004 Køge Sygehus

2002 - 2003 Rigshospitalet

2001 - 2002 Hvidovre Hospital

2001 - 2001 Bispebjerg Hospital

2000 - 2001 Radiologisk Afd., KAS Glostrup

1999 - 2000 Radiologisk Afd, KAS Glostrup

Uddannelse

1982 Studentereksamen

1988 Medicinsk kandidat på Akademia Medyczna i Warszawa.

Erfaring

Kirurgisk Afdeling, Szpital Srodmiejski i Warszawa

Børnekirurgisk Afdeling, Szpital Kopernika i Warszawa

Kirurgisk Afdeling, Frederikshavn Sygehus (uklassificeret)

Kir. Gastroenterologisk Afd., Rigshospitalet (introduktion)

Øvrig information

Publikationer

Szkudlarek J., Elsborg L. Treatment of severe obesity with a highly selective serotonin reuptake inhibitor as a supplement to a low caloric diet. Int J Obesity, 1993; 17: 681-683.

Szkudlarek J., Jeppesen PB, Brøbech PB. Treatment of severe short bowel syndrome with high dose growth hormone and glutamine. (abstract). Gastroenterology, 1998; 114: 699a.

Szkudlarek J, Heydorn, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone and glutamine on intestinal absorption and body composition in short bowel syndrome. A randomized, double blind, cross-over, placebo-controlled study. (abstract). Gastroenterology, 1999; 116: 580a.

Szkudlarek J, Jeppesen PB, Brøbech. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut. 2000 Aug;47(2):199-205.

Jeppesen PB, Szkudlarek J, Høy C.E., Mortensen PB. Effect of High-Dose Growth Hormone and Glutamine on Body Composition, Urine Creatinine Excretion, Fatty Acid Absorption, and Essential Fatty Acids Status in Short Bowel Patients. A Randomized, Double-blind, Crossover, Placebo-controlled Study. Cand J Gastroenterol 2001;36;48-54.

Szkudlarek J., Elsborg L. Treatment of severe obesity with a highly selective serotonin reuptake inhibitor as a supplement to a low caloric diet. Int J Obesity, 1993; 17: 681-683.

Szkudlarek J., Jeppesen PB, Brøbech PB. Treatment of severe short bowel syndrome with high dose growth hormone and glutamine. (abstract). Gastroenterology, 1998; 114: 699a.

Szkudlarek J, Heydorn, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone and glutamine on intestinal absorption and body composition in short bowel syndrome. A randomized, double blind, cross-over, placebo-controlled study. (abstract). Gastroenterology, 1999; 116: 580a.

Szkudlarek J, Jeppesen PB, Brøbech. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut. 2000 Aug;47(2):199-205.

Jeppesen PB, Szkudlarek J, Høy C.E., Mortensen PB. Effect of High-Dose Growth Hormone and Glutamine on Body Composition, Urine Creatinine Excretion, Fatty Acid Absorption, and Essential Fatty Acids Status in Short Bowel Patients. A Randomized, Double-blind, Crossover, Placebo-controlled Study. Cand J Gastroenterol 2001;36;48-54.